biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by greaterfoolFredon Nov 26, 2019 6:18pm

120 Views

Post# 30395596

RE:RE:RE:RE:RE:Denali/Bioasis...

Nice post JD. We all feel pain like Digitel's once in a while, but it's not about Bioasis, it's about all biotechs doing business in Canada. They get no respect. Money is hard to find and deals are hard to make. Mark Day's efforts to Americanise Bioasis should help. Now for the good news; they are all cheap as heck. Pick the right one and you are going to the moon. I think we have the right one.

Bullboard Posts

Changing Europe’s dependency on HREE from China